ÂÜÀòÂÒÂ×

Jeff Schaal is an expert in the design and recombinant engineering of drug delivery systems for radionuclide therapeutics. He has Ph.D. in Biomedical Engineering from Duke University and received a B.S. in Chemical Engineering from the University of Notre Dame.

Under the mentorship of Ashutosh Chilkoti at Duke University, he developed a thermally responsive biopolymer system for the delivery of radionuclide brachytherapy in pancreatic cancer for overcoming tumor resistance to conventional radio chemotherapy. He was awarded a NIH T32 fellowship in the pursuit of his multi-disciplinary research in tissue, cellular, and protein engineering. In addition to radiotherapeutics, his experience extends to designing novel peptide/protein materials, developing novel nanoparticle chemotherapeutics, and creating and testing animal models of tumors.

Prior to graduate school, Jeff also worked at Deloitte Consulting, LLC specializing in full life-cycle project management and enterprise system development.